Boston Scientific Medizintechnik GmbH
SpyGlassTM DS System for Direct Visualization – Dr. Hawes (Florida Hospital, Center for Interventional Endoscopy, Orlando, Florida, USA) demonstrates how to set up the new SpyGlassTM DS System and presents a case study that provided a definitive diagnosis for a patient.
Physician Controlled Wireguided Cannulation
Dr. Steven Edmundowicz, Barnes Jewish Hospital, St. Louis, Missouri, discusses the advantages of wireguided cannulation (WGC) and various cannulation techniques. He also discusses physician-controlled WGC and the benefits of using a short-wire system.
Boston Scientific is dedicated to transforming lives through innovative medical solutions that improve the health of patients around the world.
The world’s leader in less-invasive devices for gastrointestinal and pulmonary conditions.
By combining a relentless dedication to developing less-invasive endoscopy technologies with a spirit of collaboration with healthcare professionals, we’re reducing the total cost of patient care and making a meaningful and lasting impact in patients’ lives.
Delivering Meaningful Innovation
Improving Operational Efficiency. Growth in our Endoscopy business is supported by the launch of the next-generation SpyGlass™ DS Direct Visualization System. This single-use, single-operator digital cholangioscope enables physicians to see color images from inside the tiny biliary, hepatic and pancreatic ducts. When used with the SpyBite™ miniature forceps, physicians can take targeted biopsies of strictures to diagnose diseases such as cholangiocarcinoma or pancreatic cancer. When used with EHL or laser fibers, physicians can effectively and efficiently treat bile duct stones and gallstones.
New Treatment Alternatives. The AXIOS™ Stent and Electrocautery Enhanced Delivery System offers a new endoscopic alternative to surgery for transgastric or transduodenal drainage of symptomatic pancreatic pseudocysts and certain types of walled-off necrosis* – two serious complications of pancreatitis. Endoscopic solutions may offer a less invasive treatment option associated with shorter hospital stays, better physical and mental health of patients, as well as lower costs.**
Conditions We Treat
- Malignant and Benign Tumors
- Gastrointestinal diseases
- Pulmonary Diseases
- Gastrointestinal Cancers
- Severe Asthma
Solutions We Offer
- Biliary Access
- Biliary Stricture and Stone Management
- Enteral Access
- Endoscopic Ultrasound (EUS)
- Stents: Enteral & Ensophageal
- Tissue Resection
* The walled-off necrosis indication for the AXIOS Stent and Electrocautery Enhanced Delivery System is for PFCs containing less than 30 percent dead tissue.
** Varadarajulu et al, Equal Efficacy of Endoscopic and Surgical Cystogastrostomy for Pancreatic Pseudocyst Drainage in a Randomized Trial. Gastroenterology 2013; 145
Indications, Contraindications, Warnings and Instructions for Use can be found in the product labeling supplied with each device.
CAUTION: Federal (USA) law restricts this device to sale by or on the order of a physician.
All trademarks are the property of their respective owners.